Reacción #48756

ord-08ccfc082ec442ff9a7e76686e15b50e

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Concentraciónconcentrate
  2. 2
    workup.DISSOLUTIONdissolve in ethyl acetate (30 mL)
  3. 3
    Lavadowash with 1:1 saturated aqueous sodium chloride
  4. 4
    Secadosaturated aqueous sodium bicarbonate (30 mL), dry (sodium sulfate)
  5. 5
    Concentraciónconcentrate
  6. 6
    workup.DISSOLUTIONDissolve the residue in ethyl acetate
  7. 7
    Concentraciónconcentrate

Procedimiento

Dissolve (2R,5R)-2-cyclohexylmethoxy-5-[(1S,2S)-3-(3,5-difluorophenyl)-2-((E)-3-dipropylcarbamoyl-2-methylacryloylamino)-1-hydroxypropyl]-morpholine-4-carboxylic acid tert-butyl ester (0.051 g, 0.075 mmol) in trifluoroacetic acid (1.5 mL) and stir at room temperature for 15 minutes. Dilute with dichloromethane (15 mL), concentrate, dissolve in ethyl acetate (30 mL), wash with 1:1 saturated aqueous sodium chloride:saturated aqueous sodium bicarbonate (30 mL), dry (sodium sulfate) and concentrate. Dissolve the residue in ethyl acetate and add 1 M hydrogen chloride in diethyl ether (0.20 mL, 0.20 mmol) and concentrate to give the title compound (0.045 g, 97.3%).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07745438B2uspto-grants-2010_06